Concord Biotech's Unit-II clears Kenya and Uganda drug inspection

Concord Biotech's Unit-II clears Kenya and Uganda drug inspection. The company announced that the Pharmacy and Poisons Board (PPB) of Kenya and the National Drug Authority (NDA) of Uganda have completed their inspection of its formulation facility. This regulatory clearance supports export compliance and market access in East Africa. 📊 STOCKS: CONCORDBIO | 🏢 SECTOR: Pharma | #LOWIMPACT #Inspection